Hardik Onco Care
Ambawadi, Ahmedabad, Gujarat
GST No. 24AAIFH1852R1ZY
TrustSEAL Verified
Call 08048745728
88% Response Rate
SEND EMAIL
Product Details:
| Dosage Form | 150mg |
| Form of Medicine | tablets |
| Usage/Application | tumor |
| Storage Condition | room teprature |
| No of tablets | 56 |
| Composition | olaparib |
| Drug Name | olaparib |
| Packaging Type | tab |
| Dose/Strength | 150mg |
| Brand | lynparza |
Generic Content-Olaparib , Manufactured By:Astrazeneca
Olaparib is an FDA-approved targeted therapy for cancer. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase, an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.
Olaparib is indicated as monotherapy for the treatment of metastatic or locally advanced cancer in patients whose tumors are resistant.
Additional Information:
Product Details:
| Dosage Form | box |
| Form of Medicine | tablets |
| Usage/Application | cancer |
| Storage Condition | room teprature |
| Composition | olaparib |
| Drug Name | olaparib |
| Salt | olaparib |
| Packaging Type | tablets |
| Dose/Strength | 150mg |
| Brand | olaparib |
Additional Information: